181 related articles for article (PubMed ID: 15231506)
21. Time window for the contribution of the delta-opioid receptor to cardioprotection by ischemic preconditioning in the rat heart.
Tsuchida A; Miura T; Tanno M; Nozawa Y; Kita H; Shimamoto K
Cardiovasc Drugs Ther; 1998 Sep; 12(4):365-73. PubMed ID: 9825182
[TBL] [Abstract][Full Text] [Related]
22. Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning.
Dost T; Cohen MV; Downey JM
Basic Res Cardiol; 2008 Jul; 103(4):378-84. PubMed ID: 18347834
[TBL] [Abstract][Full Text] [Related]
23. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
Weinbrenner C; Schulze F; Sárváry L; Strasser RH
Cardiovasc Res; 2004 Feb; 61(3):591-9. PubMed ID: 14962489
[TBL] [Abstract][Full Text] [Related]
24. The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.
Jung O; Englert HC; Jung W; Gögelein H; Schölkens BA; Busch AE; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):445-51. PubMed ID: 10763861
[TBL] [Abstract][Full Text] [Related]
25. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
[TBL] [Abstract][Full Text] [Related]
26. An apoptosis signal-regulating kinase 1 inhibitor reduces cardiomyocyte apoptosis and infarct size in a rat ischemia-reperfusion model.
Gerczuk PZ; Breckenridge DG; Liles JT; Budas GR; Shryock JC; Belardinelli L; Kloner RA; Dai W
J Cardiovasc Pharmacol; 2012 Sep; 60(3):276-82. PubMed ID: 22635076
[TBL] [Abstract][Full Text] [Related]
27. Role of protein kinase C, K(ATP) channels and DNA fragmentation in the infarct size-reducing effects of the free radical scavenger T-0970.
Hashimoto K; Minatoguchi S; Hashimoto Y; Wang N; Qiu X; Yamashita K; Uno Y; Arai M; Nishida Y; Takemura G; Suzuki T; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):193-9. PubMed ID: 11207675
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of circulating microvesicles derived from ischemic preconditioning on myocardial ischemia/reperfusion injury in rats by inhibiting endoplasmic reticulum stress.
Liu M; Wang Y; Zhu Q; Zhao J; Wang Y; Shang M; Liu M; Wu Y; Song J; Liu Y
Apoptosis; 2018 Aug; 23(7-8):436-448. PubMed ID: 29980896
[TBL] [Abstract][Full Text] [Related]
29. Combined morphine and limb remote ischemic perconditioning provides an enhanced protection against myocardial ischemia/reperfusion injury by antiapoptosis.
Wang SY; Cui XL; Xue FS; Duan R; Li RP; Liu GP; Yang GZ; Sun C
J Surg Res; 2016 May; 202(1):13-25. PubMed ID: 27083943
[TBL] [Abstract][Full Text] [Related]
30. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
31. Differences in prolonged ischemia length using ischemic preconditioning in the rabbit heart. Tolerable limitation time for surgically induced myocardial ischemia during normothermic cardiac operation.
Uematsu M; Okada M
J Cardiovasc Surg (Torino); 2001 Jun; 42(3):323-31. PubMed ID: 11398027
[TBL] [Abstract][Full Text] [Related]
32. Effect of morphine preconditioning in the delayed phase on the expression of p38 mitogen-activated protein kinase in a rabbit model of myocardial ischemia-reperfusion injury.
Ran K; Gong ZX; Yang DL; Chang YT; Duan KM; Ou YW
Genet Mol Res; 2015 Jun; 14(2):6642-8. PubMed ID: 26125872
[TBL] [Abstract][Full Text] [Related]
33. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart.
Nakamura M; Wang NP; Zhao ZQ; Wilcox JN; Thourani V; Guyton RA; Vinten-Johansen J
Cardiovasc Res; 2000 Feb; 45(3):661-70. PubMed ID: 10728387
[TBL] [Abstract][Full Text] [Related]
34. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion.
Hausenloy DJ; Tsang A; Mocanu MM; Yellon DM
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H971-6. PubMed ID: 15358610
[TBL] [Abstract][Full Text] [Related]
35. Secreted frizzled protein 3 is a novel cardioprotective mechanism unique to the clinically relevant fourth window of ischemic preconditioning.
Vatner DE; Zhang J; Zhao X; Yan L; Kudej R; Vatner SF
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H798-H804. PubMed ID: 33337959
[TBL] [Abstract][Full Text] [Related]
36. Remote preconditioning reduces ischemic injury in the explanted heart by a KATP channel-dependent mechanism.
Kristiansen SB; Henning O; Kharbanda RK; Nielsen-Kudsk JE; Schmidt MR; Redington AN; Nielsen TT; Bøtker HE
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1252-6. PubMed ID: 15498829
[TBL] [Abstract][Full Text] [Related]
37. TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning.
Deuchar GA; Opie LH; Lecour S
Life Sci; 2007 Apr; 80(18):1686-91. PubMed ID: 17316703
[TBL] [Abstract][Full Text] [Related]
38. Involvement of opioid delta (delta)- and kappa (kappa)-receptors in ischemic preconditioning in a rat model of myocardial infarction.
Valtchanova-Matchouganska A; Ojewole JA
Methods Find Exp Clin Pharmacol; 2002 Apr; 24(3):139-44. PubMed ID: 12087875
[TBL] [Abstract][Full Text] [Related]
39. Ischemic Postconditioning-Regulated miR-499 Protects the Rat Heart Against Ischemia/Reperfusion Injury by Inhibiting Apoptosis through PDCD4.
Zhu J; Yao K; Wang Q; Guo J; Shi H; Ma L; Liu H; Gao W; Zou Y; Ge J
Cell Physiol Biochem; 2016; 39(6):2364-2380. PubMed ID: 27832626
[TBL] [Abstract][Full Text] [Related]
40. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning.
Duan Q; Madan ND; Wu J; Kalisz J; Doshi KY; Haldar SM; Liu L; Pierre SV
J Mol Cell Cardiol; 2015 Mar; 80():114-25. PubMed ID: 25575882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
